Analysts’ New Coverage for January 13th (AAPG, AMD, BMEA, CLSK, DAWN, HPE, JSPR, MGDDY, PRDSY, SEDG)

Analysts’ new coverage for Tuesday, January 13th:

Rodman & Renshaw began coverage on shares of Ascentage Pharma Group International (NASDAQ:AAPG). They issued a buy rating and a $48.00 target price on the stock.

China Renaissance began coverage on shares of Advanced Micro Devices (NASDAQ:AMD). The firm issued a buy rating and a $291.00 target price on the stock.

Rodman & Renshaw assumed coverage on shares of Biomea Fusion (NASDAQ:BMEA). The firm issued a buy rating and a $8.00 target price on the stock.

Northland Securities assumed coverage on shares of Cleanspark (NASDAQ:CLSK). The firm issued an outperform rating and a $22.50 target price on the stock.

TD Cowen began coverage on shares of Day One Biopharmaceuticals (NASDAQ:DAWN). TD Cowen issued a buy rating and a $34.00 target price on the stock.

The Goldman Sachs Group, Inc. began coverage on shares of Hewlett Packard Enterprise (NYSE:HPE). They issued a buy rating and a $31.00 target price on the stock.

Rodman & Renshaw began coverage on shares of Jasper Therapeutics (NASDAQ:JSPR). They issued a buy rating and a $17.00 price target on the stock.

Berenberg Bank assumed coverage on shares of Michelin (OTCMKTS:MGDDY). They issued a hold rating on the stock.

Barclays PLC started coverage on shares of Prada (OTCMKTS:PRDSY). The firm issued an overweight rating on the stock.

Raymond James Financial, Inc. initiated coverage on shares of SolarEdge Technologies (NASDAQ:SEDG). They issued a market perform rating on the stock.

Morgan Stanley assumed coverage on shares of Takeda Pharmaceutical (NYSE:TAK). They issued an overweight rating on the stock.

The Goldman Sachs Group, Inc. assumed coverage on shares of Veeva Systems (NYSE:VEEV). They issued a sell rating and a $215.00 price target on the stock.

LADENBURG THALM/SH SH started coverage on shares of Whitestone REIT (NYSE:WSR). LADENBURG THALM/SH SH issued a buy rating and a $17.00 target price on the stock.

Receive News & Ratings for Ascentage Pharma Group International - Unsponsored ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International - Unsponsored ADR and related companies with MarketBeat.com's FREE daily email newsletter.